Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.r r Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
This ticker group is made up of the 505 common stocks issued by the 500 large-cap companies in the S&P 500 Index. The index covers around 80% of the American equity market by capitalization and many of the stocks have options. The 30 companies in the DOW are also included in this index. The actual number of tickers used in the ranker will be less than the 505 stocks listed as only the intersection with OptionAutomator's master ticker list will be included.
This ticker group represents the intersection of top 100 capitalization-weighted companies in the NASDAQ index with the OptionAutomator's master ticker list. Companies found in the NASDAQ index (around 3000 companies) differs from other indices in that the NASDAQ includes 8 companies incorporated outside the United States and has almost a complete lack of financial companies. The index also tends to be heavily weighted in high-tech stocks and considered more risky than the DOW and S&P 500 indices.
This ticker group is the intersection of the OptionAutomator's master ticker list with the S&P 100. The S&P 100 is a subset of leading stocks in the S&P 500 index with exchange-listed options. Constituents of the S&P 100 are selected for sector balance and represent about two-thirds of the market capitalization of the S&P 500 and over half of the market capitalization of the U.S. equity markets.